Electrical Stimulation With Interferential Current in the Non-especific Chronic Low Back Pain: Effects on the Autonomic Nervous System.

June 30, 2021 updated by: Dr. Manuel Albornoz Cabello, University of Seville

The aim of this study it's to analyze the relationship between autonomic nervous system balance (ANSb) and chronic pain conditions, especially in this case, non-especific chronic low back pain (CLBP).

Most of physiotherapy approaches focus only in biomechanical aspects, leaving aside what kind of factors could perpetuate CLBP. Since 1985, ANSb was studied due to its potential contribution to chronic pain.

Electrical stimulation, through interferential currents (IFC), it's a safe and well-known therapy used in CLBP with good outcomes regarding pain relief.

The main objective of this study it's to quantify the association between CLBP and ANSb alterations. In second place, the research team aims to record the influence of IFC over pain and ANSb in those subjects.

Study Overview

Detailed Description

In the first place, a meeting will be organized with the patients to resolve any doubt about the study and its process. The investigators will make sure every instruction is understandable, giving enough time to read and ask pertinent questions.

Secondly, patients will be provided of an informed consent specific for the present study, according to the legal forms. Participants must agree with all the information and sign the document.

At this point, patients will be interviewed individually by a researcher to collect all the data regarding to the Clinical History in Physiotherapy.

In the next step, patients will be randomized into two different groups by choosing one opaque envelope, containing a number for the allocation. A researcher will make the final allocation depending on the number. Patients were unaware of the group allocation for masking.

This study has to possible groups with a common indication for both:

  1. Experimental group: Patients allocated in this group will receive one single session of interferential current (IFC). Current used a carrier frequency of 4.000 Hz, 65Hz of amplitude modulated frequency (AMF) with sweep frecuency of 95Hz in a 1:1 swing pattern (quadripolar technique). Intensity was adjusted according to patient's tolerance without visible muscle twitches. The session will last 25 min.
  2. Control group: This group will receive the same intervention than experimental one but with no intensity, for 25 minutes. Patients will keep his general practitioner's indications about pharmacology.
  3. Common indication: Both groups will get instructions to perform a set of home-based exercises for core strengthening after variable collecting.

Before and after the session, all the variable measurements will be collected in the same environmental conditions by the same researcher. Basal measurement (before intervention) will be recorded 15 minutes before session for 10 minutes. The second measurement will be taken while the patient recieves the intervention for 20 minutes.

Study Type

Interventional

Enrollment (Actual)

56

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Sevilla, Spain
        • Manuel Albornoz Cabello

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  • Subjects diagnosed with cronic low back pain with at least 3 months of evolution.
  • Subjects with a minimal pain of 3/10 according to NPRS
  • Subjects with informed consent read and signed.
  • Subjects not undergoing any other physical therapy intervention.

Exclusion Criteria:

  • Any uncontrolled neurological or cardiac disorder.
  • Personal Psychological Apprehension Scale (PPAS) score higher than 37.5.
  • Contraindication for electrical stimulation.
  • Any regular use of medications known to affect the function of the autonomic nervous system (ANS) or pain perception, including antidepressant, benzodiazepines, anti-inflammatory drugs and beta-blockers, 2 weeks before participating in this study.
  • Ineligibility to participate determined by the researches.
  • Neurological, musculoskeletal or sensory affectations.
  • Evidence of infectious process, fever or hypotension.
  • Metallic implants in low back area or treated area
  • No surgical interventions in low back area
  • Not being under pharmacological treatment with influence in Autonomic Nervous System like antidepressants.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Sham Comparator: Sham IFC therapy: Control group

This group will recieve also instructions for core strengthening exercises and a single session of interferential current (IFC).

IFC parameters:

  1. Carrier frequency of 4000 Hz
  2. Amplitude modulated frequency of 65 Hz (AMF)
  3. Sweep frequency of 95 Hz of modulation with a 1:1 swing pattern, in a quadripolar technique.
  4. NO intensity (0 mA)
  5. Session duration: 25 minutes

Application of IFC with Sonopuls 692® (Enraf-Nonius BV, Rotterdam, The Netherlands) device. Parameters:

  1. Carrier frequency of 4000 Hz
  2. Amplitude modulated frequency of 65 Hz (AMF)
  3. Sweep frequency of 95 Hz of modulation with a 1:1 swing pattern, in a quadripolar technique.
  4. NO intensity (0 mA)
  5. Session duration: 25 minutes
Experimental: IFC therapy: Experimental group

This group will recieve also instructions for core strengthening exercises and a single session of interferential current (IFC).

IFC parameters:

  1. Carrier frequency of 4000 Hz
  2. Amplitude modulated frequency of 65 Hz (AMF)
  3. Sweep frequency of 95 Hz of modulation with a 1:1 swing pattern, in a quadripolar technique.
  4. Intensity will depend on subjet's tolerance but without generating visible muscle twitches.
  5. Session duration: 25 minutes

Application of IFC with Sonopuls 692® (Enraf-Nonius BV, Rotterdam, The Netherlands) device. Parameters:

  1. Carrier frequency of 4000 Hz
  2. Amplitude modulated frequency of 65 Hz (AMF)
  3. Sweep frequency of 95 Hz of modulation with a 1:1 swing pattern, in a quadripolar technique.
  4. Intensity will depend on subjet's tolerance but without generate visible muscle twitches.
  5. Session duration: 25 minutes

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Heart Rate variability (HRV-a)
Time Frame: Evaluation before intervention (basal): 15 minutes before intervention, for 10 minutes.
Heart Rate variability (HRV) is measured by calculating mean HR, maximum HR and minimum HR. First Beat Bodyguard2 device will be used to collect HRV.
Evaluation before intervention (basal): 15 minutes before intervention, for 10 minutes.
Heart Rate variability (HRV-b)
Time Frame: Evaluation during the intervention: For 20 minutes, while the interferential current (intervention) is being applied.
Heart Rate variability (HRV) is measured by calculating mean HR, maximum HR and minimum HR. First Beat Bodyguard2 device will be used to collect HRV.
Evaluation during the intervention: For 20 minutes, while the interferential current (intervention) is being applied.
Root-mean-square differences of successive heartbeat intervals (RMSSD-a)
Time Frame: Evaluation before intervention (basal): 15 minutes before intervention, for 10 minutes.
RMSSD it's an indirect indicator of parasympathic nervous system level of activity. First Beat Bodyguard2 device will be used to collect RMSSD.
Evaluation before intervention (basal): 15 minutes before intervention, for 10 minutes.
Root-mean-square differences of successive heartbeat intervals (RMSSD-b)
Time Frame: Evaluation during the intervention: For 20 minutes, while the interferential current (intervention) is being applied.
RMSSD it's an indirect indicator of parasympathic nervous system level of activity. First Beat Bodyguard2 device will be used to collect RMSSD.
Evaluation during the intervention: For 20 minutes, while the interferential current (intervention) is being applied.
Standard Deviation 1 (SD1-a)
Time Frame: Evaluation before intervention (basal): 15 minutes before intervention, for 10 minutes.
SD1 is an indicator of the autonomic nervous balance. First Beat Bodyguard2 device will be used to collect it.
Evaluation before intervention (basal): 15 minutes before intervention, for 10 minutes.
Standard Deviation 1 (SD1-b)
Time Frame: Evaluation during the intervention: For 20 minutes, while the interferential current (intervention) is being applied.
SD1 is an indicator of the autonomic nervous balance. First Beat Bodyguard2 device will be used to collect it.
Evaluation during the intervention: For 20 minutes, while the interferential current (intervention) is being applied.
Standard Deviation 2 (SD2-a)
Time Frame: Evaluation before intervention (basal): 15 minutes before intervention, for 10 minutes.
SD2 is an indicator of the autonomic nervous balance. First Beat Bodyguard2 device will be used to collect it.
Evaluation before intervention (basal): 15 minutes before intervention, for 10 minutes.
Standard Deviation 2 (SD2-b)
Time Frame: Evaluation during the intervention: For 20 minutes, while the interferential current (intervention) is being applied.s.
SD2 is an indicator of the autonomic nervous balance. First Beat Bodyguard2 device will be used to collect it.
Evaluation during the intervention: For 20 minutes, while the interferential current (intervention) is being applied.s.
Stress Index (SS-a)
Time Frame: Evaluation before intervention (basal): 15 minutes before intervention, for 10 minutes.
SS it's an indicator of sympathetic nervous system level of activation. First Beat Bodyguard2 device will be used to collect SS.
Evaluation before intervention (basal): 15 minutes before intervention, for 10 minutes.
Stress Index (SS-b)
Time Frame: Evaluation during the intervention: For 20 minutes, while the interferential current (intervention) is being applied.s.
SS it's an indicator of sympathetic nervous system level of activation. First Beat Bodyguard2 device will be used to collect SS.
Evaluation during the intervention: For 20 minutes, while the interferential current (intervention) is being applied.s.
Sympathetic / Parasympathetic Ratio (S/PS Ratio-a)
Time Frame: Evaluation before intervention (basal): 15 minutes before intervention, for 10 minutes.
S/PS Ratio it's an indicator of autonomic nervous system balance. First Beat Bodyguard2 device will be used to collect S/PS Ratio.
Evaluation before intervention (basal): 15 minutes before intervention, for 10 minutes.
Sympathetic / Parasympathetic Ratio (S/PS Ratio-b)
Time Frame: Evaluation during the intervention: For 20 minutes, while the interferential current (intervention) is being applied.s.
S/PS Ratio it's an indicator of autonomic nervous system balance. First Beat Bodyguard2 device will be used to collect S/PS Ratio.
Evaluation during the intervention: For 20 minutes, while the interferential current (intervention) is being applied.s.
Numeric Pain Rating Scale (NPRS-a)
Time Frame: Evaluation before intervention (basal): 15 minutes before intervention.
NPRS it's an scale used to measure with ease, patient's perceived pain with a scoring of 0 (no pain) and 10 (maximum pain).
Evaluation before intervention (basal): 15 minutes before intervention.
Numeric Pain Rating Scale (NPRS-b)
Time Frame: Evaluation immediately after treatment session.
NPRS it's an scale used to measure with ease, patient's perceived pain with a scoring of 0 (no pain) and 10 (maximum pain).
Evaluation immediately after treatment session.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Roland Morris Questionnaire (RMQ-a)
Time Frame: Evaluation before intervention (basal): 15 minutes before intervention.
RMQ it's a questionnaire used to measure an individual level of disability related to low back pain, with a scoring of 0 (no disability at all) and 24 (maximum disability).
Evaluation before intervention (basal): 15 minutes before intervention.
Roland Morris Questionnaire (RMQ-b)
Time Frame: Evaluation immediately after treatment session.
RMQ it's a questionnaire used to measure an individual level of disability related to low back pain, with a scoring of 0 (no disability at all) and 24 (maximum disability).
Evaluation immediately after treatment session.
Scale for Personal Psychological Apprehension (SPPA)
Time Frame: Evaluation before intervention (basal): 15 minutes before intervention.
SPPA it's a questionnaire made to measure subject's susceptibility to receive electrical stimulation. A scoring of >45 points indicates that subject shouldnt be treated with electrical therapy.
Evaluation before intervention (basal): 15 minutes before intervention.
Dosimetry achieved with electrical stimulation
Time Frame: Recorded immediately after treatment session.
Maximal dosimetry reached during the session will be recorded in mA.
Recorded immediately after treatment session.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 1, 2020

Primary Completion (Actual)

November 1, 2020

Study Completion (Actual)

December 10, 2020

Study Registration Dates

First Submitted

July 14, 2020

First Submitted That Met QC Criteria

July 20, 2020

First Posted (Actual)

July 23, 2020

Study Record Updates

Last Update Posted (Actual)

July 2, 2021

Last Update Submitted That Met QC Criteria

June 30, 2021

Last Verified

June 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Chronic Pain

Clinical Trials on Electrical stimulation: Interferential Current (IFC): Control Group

3
Subscribe